![Christopher Mason](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Christopher Mason
Director/Board Member at KRYSTAL BIOTECH, INC.
Net worth: - $ as of 2024-05-30
Christopher Mason active positions
Companies | Position | Start | End |
---|---|---|---|
KRYSTAL BIOTECH, INC. | Director/Board Member | 2021-01-03 | - |
Independent Dir/Board Member | 2021-01-03 | - | |
Oribiotech Ltd.
![]() Oribiotech Ltd. BiotechnologyHealth Technology Oribiotech Ltd. Engages in Cell and Gene Therapy (CGT) manufacturing. The company was founded by Farlan Veraitch and Chris Mason on September 2, 2015 and is headquartered in London, the United Kingdom. | Director/Board Member | 2015-08-31 | - |
Founder | 2015-08-31 | - | |
London Regenerative Medicine Network Ltd. | Director/Board Member | 2008-01-31 | - |
Founder | 2008-01-31 | - | |
University College London | Corporate Officer/Principal | - | - |
Alliance for Regenerative Medicine
![]() Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Director/Board Member | 2021-09-30 | - |
Career history of Christopher Mason
Former positions of Christopher Mason
Companies | Position | Start | End |
---|---|---|---|
TECTONIC THERAPEUTIC, INC. | Chief Tech/Sci/R&D Officer | 2015-06-30 | 2022-06-29 |
Founder | 2015-06-30 | 2022-06-29 | |
Stem Cell Translation Ltd. | Director/Board Member | 2006-09-30 | 2018-02-28 |
Founder | 2006-09-30 | 2018-02-28 | |
The British Neurological Research Trust | Director/Board Member | 2012-04-30 | 2016-04-30 |
UK Stem Cell Foundation | Director/Board Member | 2010-08-31 | 2016-04-30 |
Training of Christopher Mason
King's College London | Doctorate Degree |
Imperial College London | Undergraduate Degree |
University College London | Doctorate Degree |
Statistics
International
United Kingdom | 9 |
United States | 4 |
Operational
Director/Board Member | 8 |
Founder | 5 |
Doctorate Degree | 2 |
Sectoral
Health Technology | 4 |
Consumer Services | 4 |
Miscellaneous | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
KRYSTAL BIOTECH, INC. | Health Technology |
Private companies | 7 |
---|---|
Avrobio, Inc.
![]() Avrobio, Inc. BiotechnologyHealth Technology AVROBIO, Inc. engages in the development of lentiviral-based gene therapies. It focuses on developing potentially curative ex vivo lentiviral-based gene therapies to treat patients with rare diseases following a single dose treatment regimen. The firm's clinical-stage programs include Fabry, Gaucher Type 1, Hunter syndrome Gaucher Type 3, Pompe, and Cystinosis. The company was founded by Geoff Mackay, Kim Warren, Christopher Mason, and Jeffrey Medin in 2015 and is headquartered in Watertown, MA. | Health Technology |
Oribiotech Ltd.
![]() Oribiotech Ltd. BiotechnologyHealth Technology Oribiotech Ltd. Engages in Cell and Gene Therapy (CGT) manufacturing. The company was founded by Farlan Veraitch and Chris Mason on September 2, 2015 and is headquartered in London, the United Kingdom. | Health Technology |
London Regenerative Medicine Network Ltd. | |
Stem Cell Translation Ltd. | |
The British Neurological Research Trust | |
UK Stem Cell Foundation | Miscellaneous |
Alliance for Regenerative Medicine
![]() Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Health Services |
- Stock Market
- Insiders
- Christopher Mason
- Experience